• Home
  • About Biowin
  • Contact us
BioWin
Win Health | The health blog of Wallonia
468 X 60
  • Biopharmacy
  • Cell therapy
  • Radiopharmacy
  • Biotech products
  • Diagnostics
  • Medical devices
  • Imaging
  • Support
    • Investment
    • Partnering

Archive for 'June,2012'

MDxHealth(Liege, Belgium and Irvine, CA) reaches milestone launching innovative prostate cancer test preventing certain men from undergoing repeat biopsies.

MDxHealth(Liege, Belgium and Irvine, CA) reaches milestone launching innovative prostate cancer test preventing certain men from undergoing repeat biopsies.

MDxHealth, a leading company in molecular diagnostics specializing in the development and commercialization of epigenetic tests to support cancer research, announces major milestone in growth and development with the launch of their first proprietary product: ConfirmMDxTM [...]

Arlenda S.A. takes a step outside Europe announcing Arlenda Inc. as their U.S. subsidiary.

Arlenda S.A. takes a step outside Europe announcing Arlenda Inc. as their U.S. subsidiary.

In the hotly competitive pharmaceutical sector, Arlenda SA(Spin-off – University of Liège, Belgium) is challenging their ability to create a space for themselves on the US market. In November 2011, Bruno Boulanger (CEO, Arlenda SA), and [...]

BioWin Day 2016

  • Popular
  • Recent
  • Comments
  • Tags
UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes

UCL makes new discovery with intestinal bacterium that may fight obesity and diabetes


June 21, 2013
Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners


January 16, 2014
Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)

Opening Bell Ceremony kicks off Advanced Therapies Investor Day (Brussels)


January 17, 2014
Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round

Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round


January 22, 2014
ZenTech Biotechnology, an example of international development!

ZenTech Biotechnology, an example of international development!


February 06, 2014
Imaging beta-cells for better diabetes treatment

Imaging beta-cells for better diabetes treatment


March 22, 2018
Walloon radioisotope in the fight against cancer

Walloon radioisotope in the fight against cancer


October 23, 2017
Personalised arthritis medicine saves lots of money

Personalised arthritis medicine saves lots of money


April 06, 2017
Adrenaline junkie? Raising capital could be for you!

Adrenaline junkie? Raising capital could be for you!


January 19, 2017
BioWin supports the ‘SMART’ project

BioWin supports the ‘SMART’ project


December 22, 2016
Arthritis Awards Biomarkers biomaterial Biotechnology BioWin Cancer Cancer Therapy cancer treatment cardiology Cell therapy Clinical Studies Clinical Trials CNS Data & Statistics Diabetes Disease DNA Genetics Gosselies heart failure Imaging Immunology in-vitro inflammation Investments & Funding joint disorders Laboratory Nuclear Medicine Obesity oncology osteoarthritis Osteonecrosis Partnering spin-off stem cell UCB UCL UCL spin-off ULB ULg UMons Updates vaccines Wallonia

Recent Posts

  • Imaging beta-cells for better diabetes treatment
  • Walloon radioisotope in the fight against cancer
  • Personalised arthritis medicine saves lots of money
  • Adrenaline junkie? Raising capital could be for you!
  • BioWin supports the ‘SMART’ project

Archives

Win Health
© 2019 Win Health | The health blog of Wallonia. All Rights Reserved.
Powered by Biowin